Pathology and function of immuno-reactive cells for cell-mediated immunity in intestinal immune system of gastric and colorectal cancer
胃癌和结直肠癌肠道免疫系统中免疫反应细胞细胞介导免疫的病理学和功能
基本信息
- 批准号:15591438
- 负责人:
- 金额:$ 1.73万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2006
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
To aim to ascertain the cell-mediated immunity in gastric and colorectal cancer, we investigated the pathology and function of cel-mediated immunity, by immunohistochemical methods for the cancer and normal tissues. The immunohistochemical studies (CD25, CD3, IgA) were performed, using the surgical specimens in the thirty two cases of gastric cancer. CD25 positive cells were identified in the cancer tissues and metastatic lymph nodes, whereas they were not recognized in normal and non-metastatic lymph nodes. The same results had been recognized in twenty eight cases of the colorectal cancer. Based on the results described the above, the excistence of tumor-infiltrating lymphocytes and activated T lymphocytes were identified in gastric and colorectal cancer. Moreover, the difference between epithelial cells of normal and cancer tissues was recognized. The intraepithelial lymphocyte(IEL) was stained by CD25 in the epithelial cells of normal tissues, whereas it was not stained in cancer t … More issues. The immunohistochemical study by IgA showed the large amount of IgA near the surface of epithelial cells in normal tissues, whereas it did not show the IgA in cancer tissues. In addition, the immunohistochemical study by CD3 revealed that CD3 positive cells were recognized both in normal and cancer tissues. According to these data, the immunological function of intraepithelial lymphocytes and mucosal barrier in cancer tissues were destroyed by cancer cells, although the activated T-lymphocytes were largely identified in cancer cells. Moreover, The Levels of serum IL-12 in 143 cases with gastric cancer showed higher than those of normal controls. The immunohistochemical study by CD68 showed that the localization and distribution of macrophages were destroyed in the gastric cancer tissues. The same result was also recognized in the colorectal cancer tissues. Therefore, the origin of high levels of serum IL-12 was not derived from macrophages in the cancer tissues. Moreover, the immunohistochemical study by CD4 showed that CD4-positive cells were identified in normal tissues. On the other hand, CD4-positive cells were not recognized in gastric and colorectal tissues. Based on these data, the destruction of helper/inducer T lymphocytes was supposed in cancer tissues. Less
为了确定胃癌和结直肠癌中的细胞介导的免疫,我们通过癌症和正常组织的免疫组织化学方法研究了细胞介导的免疫的病理学和功能。使用 32 例胃癌的手术标本进行免疫组织化学研究(CD25、CD3、IgA)。 CD25阳性细胞在癌组织和转移淋巴结中被识别,而在正常和非转移淋巴结中未被识别。在 28 例结直肠癌病例中也得到了同样的结果。基于上述结果,在胃癌和结直肠癌中鉴定出肿瘤浸润淋巴细胞和活化T淋巴细胞的存在。此外,还认识到正常组织和癌组织的上皮细胞之间的差异。正常组织上皮细胞中的上皮内淋巴细胞 (IEL) 被 CD25 染色,而癌症中则不被染色。 IgA免疫组化研究显示,正常组织中上皮细胞表面附近有大量IgA,而癌组织中未见IgA。此外,CD3的免疫组织化学研究表明,CD3阳性细胞在正常组织和癌组织中均被识别。根据这些数据,尽管癌细胞中大量发现了活化的T淋巴细胞,但癌组织中上皮内淋巴细胞和粘膜屏障的免疫功能被癌细胞破坏。此外,143例胃癌患者血清IL-12水平高于正常对照。 CD68免疫组化研究显示胃癌组织中巨噬细胞的定位和分布被破坏。在结直肠癌组织中也发现了相同的结果。因此,高水平血清IL-12的来源并非来自癌组织中的巨噬细胞。此外,CD4的免疫组织化学研究表明,在正常组织中发现了CD4阳性细胞。另一方面,CD4阳性细胞在胃和结直肠组织中未被识别。根据这些数据,推测癌组织中辅助/诱导 T 淋巴细胞被破坏。较少的
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Serum interleukin-12 in patients with gastric cancer.
胃癌患者血清白细胞介素 12。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:正木忠彦;松岡弘芳;阿部展次;他;Saburo Murakami;Saburo Murakami;Saburo Murakami
- 通讯作者:Saburo Murakami
Serum interleukin-12 levels in patients with gastric cancer
- DOI:10.1007/s00595-004-2860-z
- 发表时间:2004-12-01
- 期刊:
- 影响因子:2.5
- 作者:Murakami, S;Okubo, K;Hirayama, R
- 通讯作者:Hirayama, R
Soluble interleukin-2 receptor in cancer
- DOI:10.2741/1461
- 发表时间:2004-09-01
- 期刊:
- 影响因子:3.1
- 作者:Murakami, S
- 通讯作者:Murakami, S
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MURAKAMI Saburo其他文献
MURAKAMI Saburo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MURAKAMI Saburo', 18)}}的其他基金
Serum soluble interleukin-2 receptor and immunohistochemical staining of IL-2R/Tac antigen in gastric cancer
胃癌血清可溶性白细胞介素2受体及IL-2R/Tac抗原免疫组化染色
- 批准号:
11671269 - 财政年份:1999
- 资助金额:
$ 1.73万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Multi-layered decoding and therapeutic co-option of the metastatic checkpoint in human colorectal cancer
人类结直肠癌转移检查点的多层解码和治疗选择
- 批准号:
23K27677 - 财政年份:2024
- 资助金额:
$ 1.73万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
CanSense-CRC: early detection of colorectal cancer
CanSense-CRC:结直肠癌的早期检测
- 批准号:
10068039 - 财政年份:2023
- 资助金额:
$ 1.73万 - 项目类别:
Collaborative R&D
Investigating the Role of Drug Tolerant Persisters in Driving Colorectal Cancer Metastasis.
研究耐药性持续存在在驱动结直肠癌转移中的作用。
- 批准号:
491461 - 财政年份:2023
- 资助金额:
$ 1.73万 - 项目类别:
Fellowship Programs
Netrin-1 receptor "deleted in colorectal cancer" (DCC) signalosome in axonal development
Netrin-1 受体“在结直肠癌中缺失”(DCC) 轴突发育中的信号体
- 批准号:
488616 - 财政年份:2023
- 资助金额:
$ 1.73万 - 项目类别:
Operating Grants
The development of targeterd therapies for Intra-mitochondrial calcium ion dinamics in colorectal cancer stem cells
结直肠癌干细胞线粒体内钙离子动态靶向疗法的开发
- 批准号:
23K06654 - 财政年份:2023
- 资助金额:
$ 1.73万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The role of cell differentiation in colorectal cancer progression
细胞分化在结直肠癌进展中的作用
- 批准号:
23K06661 - 财政年份:2023
- 资助金额:
$ 1.73万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Exercise prehabilitation in colorectal cancer: establishing mechanisms of adaptation to advance optimisation and stratification.
结直肠癌的运动预康复:建立适应机制以推进优化和分层。
- 批准号:
MR/X005240/1 - 财政年份:2023
- 资助金额:
$ 1.73万 - 项目类别:
Research Grant
The regulation of hybrid-EMT and metastasis in colorectal cancer
混合EMT与结直肠癌转移的调控
- 批准号:
MR/X008762/1 - 财政年份:2023
- 资助金额:
$ 1.73万 - 项目类别:
Research Grant
Elucidation of molecular mechanisms of interaction between colorectal cancer cells and stromal cells in tumor budding area
阐明结直肠癌细胞与肿瘤出芽区基质细胞相互作用的分子机制
- 批准号:
23K15489 - 财政年份:2023
- 资助金额:
$ 1.73万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
New strategy for preventing colorectal cancer by targeting polyamines, which are thought to be carcinogens
通过针对被认为是致癌物质的多胺来预防结直肠癌的新策略
- 批准号:
23K17454 - 财政年份:2023
- 资助金额:
$ 1.73万 - 项目类别:
Grant-in-Aid for Challenging Research (Pioneering)














{{item.name}}会员




